黄体酮联合间苯三酚对先兆流产患者SOCS3表达及围生儿结局的影响

摘要
图/表
参考文献(23)
相关文章 (5)

全文: PDF (570 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探究黄体酮联合间苯三酚治疗对先兆流产患者细胞因子信号转导负调控因子3（SOCS3）表达水平和治疗后围生儿结局的影响。方法选取2015年6月~2017年6月新疆医科大学第一附属医院妇科收治的先兆流产患者94例，依据随机数表法将其分成观察组和对照组，每组47例。对照组给予黄体酮治疗，观察组在对照组基础上加用间苯三酚，比较两组临床效果、SOCS3 mRNA水平、SOCS3蛋白水平；统计妊娠期高血压、胎盘早剥、胎盘前置、胎盘早破、妊娠期糖尿病的发生情况及新生儿畸形、足月低体重儿、早产儿、新生儿死亡、1 min Apgar评分等。结果观察组有效率高于对照组，差异有统计学意义（P < 0.05）。治疗1周后，观察组SOCS3 mRNA及蛋白质水平显著高于对照组，差异有统计学意义（P < 0.05）。两组妊娠期高血压、胎盘早剥、胎盘前置、胎盘早破、妊娠期糖尿病发生情况比较，差异无统计学差异（P > 0.05）。两组新生儿畸形、足月低体重儿、早产儿、新生儿死亡率及1 min Apgar评分比较，差异无统计学意义（P > 0.05）。结论黄体酮联合间苯三酚治疗先兆流产可显著提高患者机体SOCS3水平，临床效果显著，不增加妊娠期并发症及围产儿不良结局。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	赵骏达郭春凤马俊旗▲

关键词 ：先兆流产, 黄体酮, 间苯三酚, 细胞因子信号转导负调控因子3, 围生儿结局

Abstract：objective To explore the effect of Progesterone combined with Phloroglucin on the expression suppressors of cytokine signaling 3 (SOCS3) and perinatal outcome in threatened abortion. Methods From June 2015 to June 2017, 94 cases with threatened abortion treated in Department of Gynecology, the First Affiliated Hospital, Xinjiang Medical University were seleted. According to random number table method, they were divided into the observation group and the control group, with 47 cases in each group. The control group was treated with Progesterone, while the observation group was added with Phloroglucin on the basis of the control group. The clinical treatment effect and the expression levels of SOCS3 of two groups were compared. The incidence of gestational hypertension, placental abruption, placental previa, placental premature rupture, gestational diabetes, neonatal malformation, full-term low birth weight, premature birth, neonatal death, and 1 min Apgar score were also recorded. Results The clinical treatment effect of the observation group was higher than that of the control group, and the difference was statistically significant (P < 0.05). One week after treatment, the mRNA and protein levels of SOCS3 in the observation group were significantly higher than those in the control group, with the differences were statistically significant(P < 0.05). There were no significant differences in the incidence of gestational hypertension, placental abruption, placental previa, placental premature rupture and gestational diabetes between the two groups (P > 0.05). There were no statistically significant differences between the two groups in neonatal malformation, full-term low birth weight, premature birth, neonatal death, and 1 min Apgar score (P > 0.05). Conclusion Progesterone combined with Phloroglucin in the treatment of threatened abortion clinical effect is significant, which can significantly improve the patients′ SOCS3 level and no adverse perinatal outcomes.

Key words： Threatened abortion Progesterone Phloroglucin Suppressors of cytokine signaling 3 Perinatal outcome

基金资助:新疆维吾尔自治区自然科学基金资助项目（2015 211C059）。

通讯作者: ▲通讯作者

引用本文:

赵骏达郭春凤马俊旗▲. 黄体酮联合间苯三酚对先兆流产患者SOCS3表达及围生儿结局的影响[J]. 中国医药导报, 2019, 16(35): 94-97.
ZHAO Junda GUO Chunfeng MA Junqi▲. Effect of Progesterone combined with Phloroglucin on the expression of SOCS3 and perinatal outcome in threatened abortion. 中国医药导报, 2019, 16(35): 94-97.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2019/V16/I35/94

[1] 王丽君，胡晨，吴江平.黄体功能不全先兆流产的治疗及血清孕酮值与治疗结局的相关性分析[J].现代妇产科进展，2015，24（1）：40-43.
[2] Rottenstreich A，Amsalem H，Kleinstern G，et al. Outcomes of threatened abortions after anticoagulation treatment to prevent recurrent pregnancy loss [J]. Reprod Biomed Online，2017，35（4）：461-467.
[3] 关素珍，尹金磊，宗静娟.保孕汤联合黄体酮注射液对先兆流产的临床研究[J].中药药理与临床，2015，31（4）：249-251.
[4] 卢培玲，靳桂香，刘伟，等.间苯三酚联合寿胎丸治疗妊娠12～20周先兆流产效果观察[J].山东医药，2016，56（18）：68-69.
[5] 温娜，张巧玉，王振国.细胞因子信号转导抑制因子3在早产和足月产胎盘组织中的不同表达[J].医学综述，2015， 21（15）：2828-2830.
[6] 禹彬，党飞，娟娟.黄体酮联合间苯三酚对先兆流产患者血红素氧合酶-1表达及围生儿结局的影响[J].中国妇幼保健，2016，31（21）：4526-4528.
[7] 乐杰.妇产科学[M].7版.北京：人民卫生出版社，2008：83-84.
[8] Beigi A，Esmailzadeh A，Pirjani R. Comparison of Risk of Preterm Labor between Vaginal Progesterone and 17-Alpha-Hydroxy-Progesterone Caproate in Women with Threatened Abortion：A Randomized Clinical Trial [J]. Int J Fertil Steril，2016，10（2）：162-168.
[9] 蔡志善，黄河.低剂量黄体酮注射液联合保胎无忧胶囊治疗先兆流产的疗效分析[J].中国药房，2017，28（6）：759-761.
[10] 谢萍.黄体酮疗法治疗先兆流产对妊娠期合并症及围生儿结局的影响[J].医学综述，2016，22（2）：356-358.
[11] 沈丹，陈鹰.先兆流产从瘀论治[J].中国现代医生，2017， 55（30）：134-137.
[12] 王金波，孙敏.孕酮和β亚单位人绒毛膜促性腺激素对早期先兆流产保胎结局影响的临床研究[J].临床和实验医学杂志，2018，17（19）：2115-2118.
[13] 方芳，陈晓勇.早期先兆流产合并绒毛膜下血肿的影响因素及中医证型分布规律[J].中国现代医生，2018，56（32）：129-132.
[14] Sotiriadis A，Papatheodorou S，Makrydimas G. Threatened miscarriage：evaluation and management [J]. BMJ，2004，329（7458）：152-155.
[15] 郑淑青，赵锐，郑芳，等.探讨黄体酮治疗先兆流产对围生儿结局的影响[J].中国继续医学教育，2016，8（11）：179-180.
[16] Palagiano A，Bulletti C，Pace MC，et al. Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy [J]. Ann N Y Acad Sci，2004，1034：200-210.
[17] Дубоссарская Ю А，Дубоссарская З М. Micronized progesterone use for miscarriage：discussion questions of clinical trials [J]. Reproduct Endocrinol，2016（30）：36-39.
[18] Wang Y，Zhu H，Wang D，et al. A new phloroglucionl glucoside from the whole plants of glochidion eriocarpum [J]. Bull Korean Chem Soc，2014，35（2）：631-634.
[19] 袁少飞，峰丽，石素琴，等.间苯三酚与硫酸镁治疗先兆流产疗效与安全性比较的Meta分析[J].药物流行病学杂志，2019，28（6）：355-362.
[20] Ozkan ZS，Deveci D，Simsek M，et al. What is the impact of SOCS3，IL-35 and IL17 in immune pathogenesis of recurrent pregnancy loss? [J]. J Matern Fetal Neonatal Med，2014，28（3）：324-328.
[21] 温娜，张巧玉，王振国.细胞因子信号转导抑制因子3在早产胎盘中的表达及临床意义[J].医学综述，2015， 21（18）：3394-3396.
[22] Zhang Y，Yan W，Ge PF，et al. Study on prevention effect of Zishen Yutai pill combined with progesterone for threatened abortion in rats [J]. Asian Pac J Trop Med，2016，9（6）：577-581.
[23] Ganguli P，Chowdhury S，Chowdhury S，et al. Identification of Th1/Th2 regulatory switch to promote healing response during leishmaniasis：a computational approach [J]. EURASIP J Bioinform Syst Biol，2015，2015（1）：13.